The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antiviral Drugs Market Research Report 2025

Global Antiviral Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1431784

No of Pages : 84

Ask Your Query

Report Description
Table of Content

Synopsis

Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.

The global Antiviral Drugs market was valued at US$ 1591.9 million in 2023 and is anticipated to reach US$ 2223.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.

This report aims to provide a comprehensive presentation of the global market for Antiviral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drugs.

Report Scope

The Antiviral Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie

Segment by Type

Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators

Segment by Application

Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiviral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Antiviral Drugs Market Overview
1.1 Product Overview and Scope of Antiviral Drugs
1.2 Antiviral Drugs Segment by Type
1.2.1 Global Antiviral Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.3 Antiviral Drugs Segment by Application
1.3.1 Global Antiviral Drugs Market Value by Application: (2024-2030)
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.4 Global Antiviral Drugs Market Size Estimates and Forecasts
1.4.1 Global Antiviral Drugs Revenue 2019-2030
1.4.2 Global Antiviral Drugs Sales 2019-2030
1.4.3 Global Antiviral Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antiviral Drugs Market Competition by Manufacturers
2.1 Global Antiviral Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antiviral Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antiviral Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Antiviral Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antiviral Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiviral Drugs, Product Type & Application
2.7 Antiviral Drugs Market Competitive Situation and Trends
2.7.1 Antiviral Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antiviral Drugs Players Market Share by Revenue
2.7.3 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiviral Drugs Retrospective Market Scenario by Region
3.1 Global Antiviral Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antiviral Drugs Global Antiviral Drugs Sales by Region: 2019-2030
3.2.1 Global Antiviral Drugs Sales by Region: 2019-2024
3.2.2 Global Antiviral Drugs Sales by Region: 2025-2030
3.3 Global Antiviral Drugs Global Antiviral Drugs Revenue by Region: 2019-2030
3.3.1 Global Antiviral Drugs Revenue by Region: 2019-2024
3.3.2 Global Antiviral Drugs Revenue by Region: 2025-2030
3.4 North America Antiviral Drugs Market Facts & Figures by Country
3.4.1 North America Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antiviral Drugs Sales by Country (2019-2030)
3.4.3 North America Antiviral Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antiviral Drugs Market Facts & Figures by Country
3.5.1 Europe Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antiviral Drugs Sales by Country (2019-2030)
3.5.3 Europe Antiviral Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiviral Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antiviral Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Antiviral Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antiviral Drugs Market Facts & Figures by Country
3.7.1 Latin America Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antiviral Drugs Sales by Country (2019-2030)
3.7.3 Latin America Antiviral Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiviral Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiviral Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antiviral Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antiviral Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antiviral Drugs Sales by Type (2019-2030)
4.1.1 Global Antiviral Drugs Sales by Type (2019-2024)
4.1.2 Global Antiviral Drugs Sales by Type (2025-2030)
4.1.3 Global Antiviral Drugs Sales Market Share by Type (2019-2030)
4.2 Global Antiviral Drugs Revenue by Type (2019-2030)
4.2.1 Global Antiviral Drugs Revenue by Type (2019-2024)
4.2.2 Global Antiviral Drugs Revenue by Type (2025-2030)
4.2.3 Global Antiviral Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Antiviral Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antiviral Drugs Sales by Application (2019-2030)
5.1.1 Global Antiviral Drugs Sales by Application (2019-2024)
5.1.2 Global Antiviral Drugs Sales by Application (2025-2030)
5.1.3 Global Antiviral Drugs Sales Market Share by Application (2019-2030)
5.2 Global Antiviral Drugs Revenue by Application (2019-2030)
5.2.1 Global Antiviral Drugs Revenue by Application (2019-2024)
5.2.2 Global Antiviral Drugs Revenue by Application (2025-2030)
5.2.3 Global Antiviral Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Antiviral Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Antiviral Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Antiviral Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Antiviral Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Antiviral Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bristol-Myers Squibb Antiviral Drugs Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 Gilead Sciences
6.6.1 Gilead Sciences Corporation Information
6.6.2 Gilead Sciences Description and Business Overview
6.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gilead Sciences Antiviral Drugs Product Portfolio
6.6.5 Gilead Sciences Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Antiviral Drugs Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Antiviral Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AbbVie Antiviral Drugs Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiviral Drugs Industry Chain Analysis
7.2 Antiviral Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiviral Drugs Production Mode & Process
7.4 Antiviral Drugs Sales and Marketing
7.4.1 Antiviral Drugs Sales Channels
7.4.2 Antiviral Drugs Distributors
7.5 Antiviral Drugs Customers
8 Antiviral Drugs Market Dynamics
8.1 Antiviral Drugs Industry Trends
8.2 Antiviral Drugs Market Drivers
8.3 Antiviral Drugs Market Challenges
8.4 Antiviral Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}